Isoxazolidine → 2-[(3,5'-Dichloro-2'-methoxy[1,1'-biphenyl]-4-yl)carbonyl]-isoxazolidine
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([C:18]2[CH:23]=[C:22]([Cl:24])[CH:21]=[CH:20][C:19]=2[O:25][CH2:26]C(O)=O)[CH:5]=[CH:6][C:7]=1[C:8]([N:10]1[C@@H:15](C)[CH2:14][CH2:13]C[C@H]1C)=[O:9].[O:30]1CCCN1>>[Cl:1][C:2]1[CH:3]=[C:4]([C:18]2[CH:23]=[C:22]([Cl:24])[CH:21]=[CH:20][C:19]=2[O:25][CH3:26])[CH:5]=[CH:6][C:7]=1[C:8]([N:10]1[CH2:15][CH2:14][CH2:13][O:30]1)=[O:9]Participants
3
Procedure
The sub-title compound was prepared by the method of example 21 step b) using the product of example 21 step a) and isoxazolidine.
Sources & evidence
- ORD record
- ord-45dfeeb0b58d44f2a266dbeddef52e11
- Source dataset
- uspto-grants-2010_06
- Patent number
- US07737135B2
Reaction notes
Loading…